Modulation of apolipoprotein C-III expression

Details for Australian Patent Application No. 2010200324 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Dobie, Kenneth W.; Lemonidis Tarbet, Kristina M.; Crooke, Rosanne M.; Graham, Mark J.

Agent Davies Collison Cave

Pub. Number AU-A-2010200324

Parent 2004231550

Filing date 28 January 2010

Wipo publication date 18 February 2010

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

11 February 2010 Complete Application Filed

18 February 2010 Application Open to Public Inspection

  Published as AU-A-2010200324

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010200325-Modulation of C-reactive protein expression

2010200323-Permutation Data Transform to Enhance Security